Literature DB >> 21784371

Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement.

John H Contois1, G Russell Warnick, Allan D Sniderman.   

Abstract

There is little understanding of the reliability of laboratory measurements among clinicians. Low-density lipoprotein cholesterol (LDL-C) measurement is the cornerstone of cardiovascular risk assessment and prevention, but it is fraught with error. Therefore, we have reviewed issues related to accuracy and precision for the measurement of LDL-C and the related markers non-high-density lipoprotein cholesterol (non-HDL-C) and apolipoprotein B. Despite the widespread belief that LDL-C is standardized and reproducible, available data suggest that results can vary significantly as the result of methods from different manufacturers. Similar problems with direct HDL-C assays raise concerns about the reliability of non-HDL-C measurement. The root cause of method-specific bias relates to the ambiguity in the definition of both LDL and HDL, and the heterogeneity of LDL and HDL particle size and composition. Apolipoprotein B appears to provide a more reliable alternative, but assays for it have not been as rigorously tested as direct LDL-C and HDL-C assays.
Copyright © 2011 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784371     DOI: 10.1016/j.jacl.2011.05.004

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  21 in total

1.  The proteome of postsurgical pancreatic juice.

Authors:  Giovanni Marchegiani; Joao A Paulo; Klaus Sahora; Carlos Fernández-Del Castillo
Journal:  Pancreas       Date:  2015-05       Impact factor: 3.327

2.  Evaluation of four different equations for calculating LDL-C with eight different direct HDL-C assays.

Authors:  Marcelo Jose Andrade Oliveira; Hendrick E van Deventer; Lorin M Bachmann; G Russell Warnick; Katsuyuki Nakajima; Masakasu Nakamura; Ikunosuke Sakurabayashi; Mary M Kimberly; Robert D Shamburek; William J Korzun; Gary L Myers; W Greg Miller; Alan T Remaley
Journal:  Clin Chim Acta       Date:  2013-04-27       Impact factor: 3.786

3.  Pharmacists' Utilization of Non-HDL-C Levels in Managing Patients With Lipid Disorders.

Authors:  Roda Plakogiannis; Joseph J Saseen; Abraham Stefanidis
Journal:  Hosp Pharm       Date:  2020-03-06

4.  LDL cholesterol performance of beta quantification reference measurement procedure.

Authors:  Masakazu Nakamura; Yuzo Kayamori; Hiroyasu Iso; Akihiko Kitamura; Masahiko Kiyama; Isao Koyama; Kunihiro Nishimura; Michikazu Nakai; Hiroyuki Noda; Mahnaz Dasti; Hubert W Vesper; Yoshihiro Miyamoto
Journal:  Clin Chim Acta       Date:  2014-02-28       Impact factor: 3.786

Review 5.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Nosocomial infections after severe trauma are associated with lower apolipoproteins B and AII.

Authors:  Jon K Femling; Sonlee D West; Erik K Hauswald; Hattie D Gresham; Pamela R Hall
Journal:  J Trauma Acute Care Surg       Date:  2013-04       Impact factor: 3.313

7.  High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease.

Authors:  Verena Zuber; Dipender Gill; Mika Ala-Korpela; Claudia Langenberg; Adam Butterworth; Leonardo Bottolo; Stephen Burgess
Journal:  Int J Epidemiol       Date:  2021-07-09       Impact factor: 7.196

8.  Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study.

Authors:  Hirohito Sone; Sachiko Tanaka; Shiro Tanaka; Satoshi Iimuro; Shun Ishibashi; Shinichi Oikawa; Hitoshi Shimano; Shigehiro Katayama; Yasuo Ohashi; Yasuo Akanuma; Nobuhiro Yamada
Journal:  Diabetes Care       Date:  2012-02-14       Impact factor: 19.112

9.  Robust methods to correct for measurement error when evaluating a surrogate marker.

Authors:  Layla Parast; Tanya P Garcia; Ross L Prentice; Raymond J Carroll
Journal:  Biometrics       Date:  2020-10-16       Impact factor: 1.701

10.  Association of the apolipoprotein b/apolipoprotein a-I ratio, metabolic syndrome components, total cholesterol, and low-density lipoprotein cholesterol with insulin resistance in the population of georgia.

Authors:  Zaza Makaridze; Elene Giorgadze; Ketevan Asatiani
Journal:  Int J Endocrinol       Date:  2014-05-13       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.